
Ep. 582 PERT Consortium Recap: New Developments in PE with Dr. Jonathan Paul and Dr. Osman Ahmed
15 snips
Oct 17, 2025 Dr. Jonathan Paul and Dr. Osman Ahmed, experts in interventional cardiology and radiology, share insights from the recent PERT Consortium in San Diego. They delve into cutting-edge developments in pulmonary embolism (PE) treatment, including advancements in thrombectomy devices and the importance of combined therapies. The conversation also highlights their collaboration at Flow Medical, focusing on a novel device that provides real-time pulmonary artery pressure feedback. Their passion for innovation and data-driven approaches promises a transformative future for PE care.
AI Snips
Chapters
Transcript
Episode notes
Big Acquirers Are Shaping Device Access
- Major acquisitions (e.g., Inari by Stryker) signal large-company interest and will shape which devices hospitals can stock.
- Market consolidation and contracts will influence real-world device availability.
Flow Born From Cardiology–IR Collaboration
- Jonathan Paul and Osman Ahmed formed Flow by bridging cardiology and IR silos and combining complementary skills.
- They emphasize treating the entire pulmonary vasculature and minimizing residual occlusion after intervention.
Real-Time PA Pressure–Guided Thrombolysis
- Flow prioritizes precision thrombolysis guided by real-time pulmonary artery pressures to tailor dosing and duration.
- Their device integrates a fiber-optic PA pressure sensor to stop dosing at diminishing returns.
